AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22281781 — intervention group
Group type: COMPARATOR
Intervention: Subacromial corticosteroid injections
Number of subjects: 92
Study 21176307 — intervention group
Group type: EXPERIMENTAL
Intervention: goserelin 3.6 mg one month before ablation
Number of subjects: 105
Study 21176307 — intervention group
Group type: COMPARATOR
Intervention: suction curettage immediately before ablation
Number of subjects: 105
Study 17958584 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 U of BTX‐A reconstituted and refrigerated at 4 degrees C 1 week before application
Number of subjects: 30
Study 17958584 — intervention group
Group type: COMPARATOR
Intervention: 15 U of fresh BTX‐A
Number of subjects: 30
Study 14766487 — intervention group
Group type: EXPERIMENTAL
Intervention: Random practice
Number of subjects: 30
Study 14766487 — intervention group
Group type: COMPARATOR
Intervention: Blocked practice
Number of subjects: 30
Study 12630494 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified beverage (F)
Number of subjects: 439
Study 12630494 — intervention group
Group type: COMPARATOR
Intervention: Non-fortified beverage (NF)
Number of subjects: 439
Study 12630494 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 439
Study 9743784 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (urban general practice attachment organized by project team)
Number of subjects: 100
Study 9743784 — intervention group
Group type: COMPARATOR
Intervention: Standard student attachment (control group)
Number of subjects: 100
Study 8113064 — intervention group
Group type: EXPERIMENTAL
Intervention: CATCH PE teacher training and in-service support
Number of subjects: 0
Study 8113064 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring training and support
Number of subjects: 0
Study 8113064 — intervention group
Group type: EXPERIMENTAL
Intervention: Curriculum implementation
Number of subjects: 0
Study 3289357 — intervention group
Group type: EXPERIMENTAL
Intervention: APSAC (30 U intravenously over 5 minutes)
Number of subjects: 85
Study 3289357 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase (250,000 IU intracoronary infusion over 90 minutes)
Number of subjects: 85
Study 30744396 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy for insomnia (CBT-I)
Number of subjects: 31
Study 30744396 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy for insomnia plus positive mood strategies (CBT-I+)
Number of subjects: 31
Study 30744396 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy for insomnia (CBT-I) and CBT-I+
Number of subjects: 31
Study 30246890 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain HN001
Number of subjects: 474
Study 30246890 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis strain HN019
Number of subjects: 474
Study 30246890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 474
Study 27997254 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline adherence for COPD exacerbation treatment
Number of subjects: 378
Study 25677074 — intervention group
Group type: EXPERIMENTAL
Intervention: STN 200 mg b.i.d. + standard-exposure TAC (n=50)
Number of subjects: 204
Study 25677074 — intervention group
Group type: EXPERIMENTAL
Intervention: STN 200 mg b.i.d. + reduced-exposure TAC (n=52)
Number of subjects: 204
Study 25677074 — intervention group
Group type: EXPERIMENTAL
Intervention: STN 300 mg b.i.d. + reduced-exposure TAC (n=50)
Number of subjects: 204
Study 25677074 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) 1 g b.i.d. + standard-exposure TAC (control, n=52)
Number of subjects: 204
Study 23334562 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 101
Study 23334562 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 101
Study 20559306 — intervention group
Group type: EXPERIMENTAL
Intervention: HI PA diet
Number of subjects: 24
Study 20559306 — intervention group
Group type: EXPERIMENTAL
Intervention: HI OA diet
Number of subjects: 24
Study 18936478 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related differences in recall of information during oncology consultations
Number of subjects: 260
Study 18936478 — intervention group
Group type: EXPERIMENTAL
Intervention: Amount of information presented
Number of subjects: 260
Study 18936478 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognosis information provided
Number of subjects: 260
Study 16608929 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional evaluation plus spirometry
Number of subjects: 333
Study 16608929 — intervention group
Group type: COMPARATOR
Intervention: Conventional evaluation alone
Number of subjects: 333
Study 14616490 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied three times a week for 3 weeks
Number of subjects: 39
Study 14616490 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream applied three times a week for 3 weeks
Number of subjects: 39
Study 11185326 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder postcard
Number of subjects: 0
Study 11185326 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder telephone call
Number of subjects: 0
Study 11185326 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational telephone call
Number of subjects: 0
Study 11185326 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder postcard (among women with no previous mammography)
Number of subjects: 0
Study 11185326 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder telephone call (among women with no previous mammography)
Number of subjects: 0
Study 8829162 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine mouthwash
Number of subjects: 222
Study 8829162 — intervention group
Group type: COMPARATOR
Intervention: Sterile water mouthwash (placebo)
Number of subjects: 222
Study 8829162 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA program (both groups)
Number of subjects: 222
Study 8101024 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol 100 mg
Number of subjects: 20
Study 8101024 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 8101024 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 20
Study 2946838 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased sodium intake (NaCl 4.6 mmol/kg/d)
Number of subjects: 0
Study 2946838 — intervention group
Group type: COMPARATOR
Intervention: Low sodium intake (1.5 mmol/kg/d)
Number of subjects: 0
Study 29893477 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-prepared platelet rich fibrin (T-PRF)
Number of subjects: 18
Study 29893477 — intervention group
Group type: COMPARATOR
Intervention: Allografts
Number of subjects: 18
Study 29893477 — intervention group
Group type: EXPERIMENTAL
Intervention: T-PRF
Number of subjects: 18
Study 28028979 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward walking training
Number of subjects: 65
Study 28028979 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward walking training
Number of subjects: 65
Study 28028979 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine physiotherapy)
Number of subjects: 65
Study 25578869 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral metronomic chemotherapy (daily celecoxib 200mg twice daily and weekly methotrexate 15mg/m²)
Number of subjects: 110
Study 25578869 — intervention group
Group type: COMPARATOR
Intervention: Intravenous single agent cisplatin (75mg/m² every 3 weeks)
Number of subjects: 110
Study 24013058 — intervention group
Group type: EXPERIMENTAL
Intervention: Mipomersen 200 mg weekly for 26 weeks
Number of subjects: 158
Study 24013058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 21903881 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g cocoa
Number of subjects: 23
Study 21903881 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g cocoa
Number of subjects: 23
Study 21903881 — intervention group
Group type: EXPERIMENTAL
Intervention: 13 g cocoa
Number of subjects: 23
Study 21903881 — intervention group
Group type: EXPERIMENTAL
Intervention: 26 g cocoa
Number of subjects: 23
Study 21903881 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 g cocoa)
Number of subjects: 23
Study 19021713 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental history of myocardial infarction before age 55
Number of subjects: 20187
Study 19021713 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental history of myocardial infarction at age 55-59
Number of subjects: 20187
Study 19021713 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental history of myocardial infarction at age 60-64
Number of subjects: 20187
Study 19021713 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental history of myocardial infarction at age 65+
Number of subjects: 20187
Study 19021713 — intervention group
Group type: COMPARATOR
Intervention: No parental history of myocardial infarction
Number of subjects: 20187
Study 17472022 — intervention group
Group type: EXPERIMENTAL
Intervention: perindopril 2 mg + indapamide 0.625 mg
Number of subjects: 216
Study 17472022 — intervention group
Group type: COMPARATOR
Intervention: placebo (substituted for perindopril 2 mg + indapamide 0.625 mg)
Number of subjects: 216
Study 12829659 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive, individualized diet and exercise intervention
Number of subjects: 490
Study 12829659 — intervention group
Group type: EXPERIMENTAL
Intervention: Both the A allele of the TNF-α gene and the C-174C genotype of the IL-6 gene
Number of subjects: 490
Study 12829659 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 490
Study 10859075 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted sigmoid resection after re-establishing pneumoperitoneum
Number of subjects: 31
Study 10859075 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic-assisted sigmoid resection with anastomosis performed in an open fashion through a horizontal suprapubic incision
Number of subjects: 31
Study 9169739 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate-ascorbic acid buffer
Number of subjects: 39
Study 9169739 — intervention group
Group type: EXPERIMENTAL
Intervention: Alka-Seltzer
Number of subjects: 39
Study 9169739 — intervention group
Group type: EXPERIMENTAL
Intervention: CeraVacx
Number of subjects: 39
Study 9169739 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 39
Study 8460760 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 1.0 mg.kg‐1
Number of subjects: 198
Study 8460760 — intervention group
Group type: COMPARATOR
Intervention: Papaveretum 0.2 mg.kg‐1
Number of subjects: 198
Study 3958345 — intervention group
Group type: EXPERIMENTAL
Intervention: High pulse repetition frequency Doppler echocardiography
Number of subjects: 125
Study 3958345 — intervention group
Group type: COMPARATOR
Intervention: Continuous wave Doppler echocardiography
Number of subjects: 125
Study 29415163 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine administration
Number of subjects: 50
Study 29415163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 29540164 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical exercise efficacy trial for participants with neurologic disability (multiple sclerosis)
Number of subjects: 0
Study 29540164 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based teleexercise trial
Number of subjects: 0
Study 29952453 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% sodium hyaluronate plus 0.5% mannitol
Number of subjects: 20
Study 24948048 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (50mg at 0, 12, and 24h, total 150mg) + Ethacridine lactate (100mg)
Number of subjects: 276
Study 24948048 — intervention group
Group type: COMPARATOR
Intervention: Ethacridine lactate (100mg) alone
Number of subjects: 276
Study 21934474 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 83
Study 21934474 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 83
Study 20471178 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor (letrozole 2.5 mg)
Number of subjects: 21
Study 20471178 — intervention group
Group type: COMPARATOR
Intervention: Combination of aromatase inhibitor and estradiol (75 μg/24 h)
Number of subjects: 21
Study 18805118 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aortic stenosis (AS) patients
Number of subjects: 50
Study 15780145 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term TTO exercise
Number of subjects: 515
Study 15780145 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term TTO exercise
Number of subjects: 515
Study 15780145 — intervention group
Group type: EXPERIMENTAL
Intervention: TTO and CV exercises
Number of subjects: 515
Study 12432288 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled anopexy
Number of subjects: 99
Study 12432288 — intervention group
Group type: COMPARATOR
Intervention: Open hemorrhoidectomy
Number of subjects: 99
Study 10478767 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced color‐coded duplex sonography during cervical rotation
Number of subjects: 20
Study 10478767 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced color‐coded duplex sonography after spinal manipulation therapy
Number of subjects: 20
Study 8960787 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg simvastatin
Number of subjects: 36
Study 8960787 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin
Number of subjects: 36
Study 8960787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 1292787 — intervention group
Group type: EXPERIMENTAL
Intervention: Fotemustine (FM) alone on days 1, 8, 15 followed by a 5-week rest period
Number of subjects: 24
Study 1292787 — intervention group
Group type: EXPERIMENTAL
Intervention: Fotemustine (FM) administered on days 1 and 8 alternating with Dacarbazine (DTIC) on days 15 and 16, followed by a 5-week rest period
Number of subjects: 24
Study 1292787 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacarbazine (DTIC) followed 4 hours later by Fotemustine (FM)
Number of subjects: 24
Study 2991051 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate/high fibre/low fat diet (group C)
Number of subjects: 40
Study 2991051 — intervention group
Group type: COMPARATOR
Intervention: Conventional low carbohydrate diet (group B)
Number of subjects: 40
Study 2991051 — intervention group
Group type: COMPARATOR
Intervention: Conventional low carbohydrate diet (group A)
Number of subjects: 40
Study 31363901 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 94
Study 31363901 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 94
Study 30241119 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBO2) for four weeks in addition to routine therapy
Number of subjects: 98
Study 30241119 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only (Control group)
Number of subjects: 98
Study 30241119 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBO2)
Number of subjects: 98
Study 26970160 — intervention group
Group type: EXPERIMENTAL
Intervention: MicronJet600 microneedle
Number of subjects: 100
Study 26970160 — intervention group
Group type: COMPARATOR
Intervention: Conventional needle
Number of subjects: 100
Study 25373872 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyaxial locking plate (NCB®, Zimmer)
Number of subjects: 14
Study 25373872 — intervention group
Group type: COMPARATOR
Intervention: Monoaxial locking plate (PERILOC®, Smith & Nephew)
Number of subjects: 14
Study 23213976 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zhigou (TE 6) and Zusanli (ST 36)
Number of subjects: 40
Study 23213976 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture at non-acupoint sites
Number of subjects: 40
Study 19675319 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence tracking and alert system
Number of subjects: 2293
Study 19675319 — intervention group
Group type: COMPARATOR
Intervention: Active medication list alone
Number of subjects: 2293
Study 18768036 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-high-fat snack (30 g CHO, 2 g protein, 20 g fat; 320 kcal)
Number of subjects: 10
Study 18768036 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate-low-fat snack (30 g CHO, 2.5 g protein, 1.3 g fat; 138 kcal)
Number of subjects: 10
Study 15567456 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet drugs
Number of subjects: 88
Study 11880007 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolith DSE (fast release profile)
Number of subjects: 0
Study 11880007 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolith SDE (slower release profile)
Number of subjects: 0
Study 12080647 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP) - clamping of the main pulmonary artery for 10 minutes followed by 10 minutes of release (Group IP)
Number of subjects: 20
Study 12080647 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) - no ischemic preconditioning (Group C)
Number of subjects: 20
Study 7718710 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic salmon calcitonin (100 daily I.U. nasally administered) plus 500 mg of calcium per day
Number of subjects: 88
Study 7718710 — intervention group
Group type: COMPARATOR
Intervention: Calcium (1 g per day)
Number of subjects: 88
Study 1786130 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Polydioxanone
Number of subjects: 99
Study 1786130 — intervention group
Group type: COMPARATOR
Intervention: Interrupted Neurilon
Number of subjects: 99
Study 6688772 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 0.5 mg/kg
Number of subjects: 27
Study 6688772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 31847830 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily for 90 days
Number of subjects: 222
Study 31847830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 30033617 — intervention group
Group type: COMPARATOR
Intervention: Informative power prior from historical data
Number of subjects: 0
Study 30033617 — intervention group
Group type: EXPERIMENTAL
Intervention: New trial data
Number of subjects: 0
Study 30033617 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninformative prior
Number of subjects: 0
Study 30033617 — intervention group
Group type: EXPERIMENTAL
Intervention: Early stopping rule
Number of subjects: 0
Study 30033617 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed design methodology
Number of subjects: 0
Study 30033617 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular outcomes trial
Number of subjects: 0
Study 26955673 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Tripterygium wilfordii Hook F. (TwHF)
Number of subjects: 174
Study 26955673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 24768518 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine at 0.5 μg/kg/h (LDA)
Number of subjects: 6
Study 24768518 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine at 1 μg/kg/h (HDA)
Number of subjects: 6
Study 24768518 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) with no dexmedetomidine
Number of subjects: 6
Study 24768518 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (both LDA and HDA)
Number of subjects: 6
Study 22033349 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) - 1g bolus followed by infusion at 200mg/h
Number of subjects: 76
Study 22033349 — intervention group
Group type: COMPARATOR
Intervention: Control group - saline infusion
Number of subjects: 76
Study 20840481 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus BID (twice-daily)
Number of subjects: 475
Study 20840481 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus QD (once-daily)
Number of subjects: 475
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric antibiotics to reduce chorioamnionitis-related perinatal HIV transmission
Number of subjects: 2434
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous stillbirth
Number of subjects: 2434
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal hemorrhage
Number of subjects: 2434
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical chorioamnionitis
Number of subjects: 2434
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: Marked polymorphonuclear infiltration on placental histology
Number of subjects: 2434
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancies at 34-37 weeks
Number of subjects: 2434
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancies at less than 34 weeks
Number of subjects: 2434
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infection
Number of subjects: 2434
Study 17978109 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing CD4 cell count among HIV-infected women
Number of subjects: 2434
Study 16334698 — intervention group
Group type: EXPERIMENTAL
Intervention: High Variability Phonetic Training (natural words from multiple talkers)
Number of subjects: 0
Study 16334698 — intervention group
Group type: EXPERIMENTAL
Intervention: All Enhancement (F3 contrast maximized and closure duration lengthened)
Number of subjects: 0
Study 16334698 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual Fading (F3 enhancement reduced during training)
Number of subjects: 0
Study 16334698 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary Cue Variability (variation in F2 and durations increased during training)
Number of subjects: 0
Study 11970761 — intervention group
Group type: EXPERIMENTAL
Intervention: Denileukin diftitox 9 microg/kg/day or 18 microg/kg/day, administered intravenously over 15-60 minutes for 5 consecutive days, cycles every 21 days for a total of 8 cycles over 6 months.
Number of subjects: 71
Study 11970761 — intervention group
Group type: EXPERIMENTAL
Intervention: Denileukin diftitox (responders),
Number of subjects: 71
Study 10323055 — intervention group
Group type: EXPERIMENTAL
Intervention: NPH Insulin (20 to 40 units at bedtime)
Number of subjects: 36
Study 10323055 — intervention group
Group type: COMPARATOR
Intervention: Metformin (up to 3 grams) combined with Sulphonylureas
Number of subjects: 36
Study 8129407 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% topical minoxidil solution
Number of subjects: 308